Announcements

The Foundation’s Role in Advancing Medical Product Development in the United States
Read More
Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development Written Testimony
Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development Written Testimony
Read More
Call for Nominations for the 2026 Innovations in Regulatory Science & Policy Awards
The Reagan-Udall Foundation for the FDA invites nominations for its annual Innovations in Regulatory Science & Policy Awards.
Read More
More Announcements

Coverage

FDA Plans Cannabis Public Health Messaging Initiative With Consumer and Healthcare Provider Testing
FDA intends to award a sole-source contract to the Reagan-Udall Foundation for the FDA to carry out 16 regulatory science and public health projects, including a dedicated project titled “Cannabis Public Health Message Testing.”
Read More
Spruce Biosciences at H.C. Wainwright: BLA Path Comes into Focus
The regulatory picture changed in February 2024, when the FDA held a Reagan-Udall Foundation forum on neuronopathic mucopolysaccharidoses.
Read More
Why CDC Opioid Guidelines Get the Overdose Data Wrong
On Wednesday, September 9, 2026, the author spoke briefly at a hybrid conference conducted by the Reagan-Udall Foundation for the U.S. Food and Drug Administration in Washington, D.C.
Read More
More Coverage